FDA halts Amgen study after teen patient death
Tuesday, February 26, 2013 - 15:00
in Health & Medicine
WASHINGTON (AP) -- Federal health regulators say they have halted Amgen's studies of its thyroid drug Sensipar after the death of a 14-year-old patient in a company trial....